Q3 Earnings Forecast for SBC Medical Group Issued By Sidoti

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) – Stock analysts at Sidoti upped their Q3 2026 earnings per share estimates for SBC Medical Group in a research note issued on Monday, August 17th. Sidoti analyst A. Shah now expects that the company will post earnings of $0.12 per share for the quarter, up from their prior estimate of $0.11. The consensus estimate for SBC Medical Group’s current full-year earnings is $0.47 per share. Sidoti also issued estimates for SBC Medical Group’s Q4 2026 earnings at $0.12 EPS, FY2026 earnings at $0.47 EPS, Q1 2027 earnings at $0.12 EPS, Q2 2027 earnings at $0.13 EPS, Q3 2027 earnings at $0.14 EPS and FY2027 earnings at $0.52 EPS.

A number of other research firms also recently commented on SBC. Weiss Ratings downgraded SBC Medical Group from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Friday, May 22nd. BTIG Research reissued a “buy” rating and set a $8.00 price target on shares of SBC Medical Group in a research report on Thursday, August 13th. Finally, Wall Street Zen upgraded SBC Medical Group from a “hold” rating to a “buy” rating in a research note on Saturday. Two analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, SBC Medical Group presently has a consensus rating of “Hold” and a consensus target price of $8.50.

SBC Medical Group Price Performance

Shares of SBC stock opened at $3.65 on Tuesday. The firm has a fifty day moving average of $3.10 and a two-hundred day moving average of $3.55. The firm has a market cap of $374.42 million, a P/E ratio of 7.77 and a beta of 0.59. SBC Medical Group has a 1-year low of $2.78 and a 1-year high of $5.07. The company has a debt-to-equity ratio of 0.09, a current ratio of 3.31 and a quick ratio of 3.27.

SBC Medical Group (NASDAQ:SBC) last announced its earnings results on Thursday, August 13th. The company reported $0.10 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.02). SBC Medical Group had a net margin of 27.99% and a return on equity of 18.47%. The business had revenue of $49.19 million during the quarter, compared to analyst estimates of $45.37 million.

Hedge Funds Weigh In On SBC Medical Group

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Bank of America Corp DE acquired a new stake in SBC Medical Group in the 2nd quarter worth approximately $35,000. Bank of New York Mellon Corp acquired a new position in shares of SBC Medical Group in the 1st quarter valued at $43,000. Goldman Sachs Group Inc. acquired a new position in shares of SBC Medical Group in the 4th quarter valued at $49,000. Russell Investments Group Ltd. lifted its holdings in shares of SBC Medical Group by 292.0% during the 4th quarter. Russell Investments Group Ltd. now owns 11,775 shares of the company’s stock worth $51,000 after acquiring an additional 8,771 shares during the period. Finally, Nuveen LLC bought a new position in shares of SBC Medical Group during the 4th quarter worth about $53,000. Institutional investors and hedge funds own 60.82% of the company’s stock.

SBC Medical Group Company Profile

SBC Medical Group, Inc is a publicly traded healthcare management services company listed on the Nasdaq under the ticker SBC. The company specializes in supporting in-office ancillary service providers by offering a suite of administrative and operational solutions designed to streamline practice management and enhance revenue performance. Its core mission is to help physician practices, imaging centers and other ancillary service providers focus on patient care while outsourcing complex back-office functions.

The company’s primary offerings include revenue cycle management, medical billing and coding, compliance oversight and transcription services.